Status:
ENROLLING_BY_INVITATION
Hippocampal Network Function in Epilepsy
Lead Sponsor:
University of Chicago
Conditions:
Mesial Temporal Lobe Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this pilot study is to understand hippocampal network function in mesial temporal lobe epilepsy (MTLE) and to test whether transcranial magnetic stimulation (TMS) targeting the network of t...
Detailed Description
The purpose of this pilot study is to investigate hippocampal network dysfunction associated with mesial temporal lobe epilepsy (MTLE) and to examine whether network-targeted transcranial magnetic sti...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of (pharmacoresistant) MTLE
- Age 18+ years old
- Native English speakers
- Normal or corrected-to-normal near and far vision
- Stable antiepileptic drugs (AED) regimen (unchanged for at least 1 month)
- Exclusion criteria:
- Diagnosis of neurological illness other than MTLE
- Taking drugs that impair cognition other than anticonvulsive medication for the treatment of MTLE (e.g., antipsychotics or psychostimulants).
- Children under the age of 18 years
Exclusion
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06521437
Start Date
July 1 2024
End Date
December 1 2028
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637